Solexa Developments

Solexa and Lynx Therapeutics have completed their merger.  Solexa is now up and running on the NASDAQ with the ticker SLXA.  They are developing technology that promises to bring down the cost of sequencing.  They recently completed their first full genome sequencing job using their new "DNA cluster" technology.

Comments

Comments are closed.